Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193178 · ClinicalTrials.gov registry record · NA
Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02193178 is a NA study that has completed, run by CooperVision. The registered enrollment target is 15 participants.
The verdict
NCT02193178, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.
Interventions
- DEVICE comfilcon A Toric
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02193178
The ClinicalTrials.gov registry entry for NCT02193178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which comfilcon A Toric is the first listed.
NCT02193178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02193178 about?
NCT02193178 is a clinical study titled "Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges". The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.
What is the current status of trial NCT02193178?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02193178?
The interventions under investigation include: comfilcon A Toric (DEVICE).
Who is sponsoring clinical trial NCT02193178?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.